UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.30 Million Holdings in Astrana Health, Inc. (NASDAQ:ASTH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 15.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 104,658 shares of the company's stock after buying an additional 14,138 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.19% of Astrana Health worth $3,300,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in ASTH. Vanguard Group Inc. lifted its holdings in Astrana Health by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 4,685,959 shares of the company's stock valued at $147,748,000 after acquiring an additional 20,757 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Astrana Health by 10.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,045,540 shares of the company's stock valued at $32,968,000 after purchasing an additional 101,192 shares during the last quarter. 325 Capital LLC boosted its holdings in Astrana Health by 30.3% during the fourth quarter. 325 Capital LLC now owns 886,916 shares of the company's stock worth $27,964,000 after buying an additional 206,009 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Astrana Health by 5.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 471,329 shares of the company's stock worth $14,861,000 after buying an additional 23,533 shares in the last quarter. Finally, Northern Trust Corp grew its position in Astrana Health by 10.1% in the fourth quarter. Northern Trust Corp now owns 467,179 shares of the company's stock worth $14,730,000 after buying an additional 43,032 shares during the last quarter. 52.77% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on ASTH. Robert W. Baird cut their price objective on Astrana Health from $86.00 to $50.00 and set an "outperform" rating for the company in a research report on Monday, March 3rd. Truist Financial decreased their price target on Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research report on Tuesday, March 18th. Stifel Nicolaus dropped their price target on Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a research note on Thursday, February 20th. Barclays started coverage on Astrana Health in a report on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 price objective on the stock. Finally, Bank of America decreased their target price on shares of Astrana Health from $55.00 to $49.00 and set a "buy" rating for the company in a report on Tuesday, March 4th. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $53.29.

Astrana Health Stock Up 0.1%

Shares of ASTH stock traded up $0.02 during trading on Monday, hitting $25.28. 191,371 shares of the company were exchanged, compared to its average volume of 291,742. The business's 50-day simple moving average is $29.12 and its 200 day simple moving average is $32.82. Astrana Health, Inc. has a twelve month low of $23.12 and a twelve month high of $63.20. The firm has a market capitalization of $1.42 billion, a price-to-earnings ratio of 19.45, a P/E/G ratio of 1.37 and a beta of 0.85. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $620.39 million during the quarter, compared to analyst estimates of $628.11 million. During the same period last year, the company posted $0.31 earnings per share. The company's revenue was up 53.4% compared to the same quarter last year. As a group, analysts forecast that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.